Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0001628279-22-000192
Filing Date
2022-04-08
Accepted
2022-04-08 15:42:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 16679
  Complete submission text file 0001628279-22-000192.txt   17536
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)